Status:
RECRUITING
Breast Cancer Proteomics and Molecular Heterogeneity
Lead Sponsor:
Cancer Trials Ireland
Conditions:
Primary Breast Cancer
Recurrent/Metastatic Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Primary objective: The primary objective is to define the proteomic and molecular characteristics of primary and recurrent/ metastatic breast tumours with special focus on the expression of S100 prot...
Detailed Description
This is a translational study. Patient will undergo standard treatment and tissue and blood samples will be taken at various time points: Tissue: Fresh frozen (FF) and Formalin fixed paraffin embedde...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients diagnosed with primary breast cancer attending hospital for the resection of their tumour tissue
- Or
- Patients with suspected or confirmed recurrent or metastatic breast cancer (Patient has a history of a biopsy- or surgically- (i.e. pathologically) confirmed primary breast cancer) attending hospital for the resection/biopsy and/or treatment of tumour tissue
- Or
- Patient with suspected (but not necessarily biopsy confirmed) newly diagnosed stage 4 breast cancer attending hospital for the resection/biopsy and/or treatment of their tumour tissue
- Patients receiving neoadjuvant treatment are also eligible (if applicable)
- Patients have to be ≥ 18 years of age
- Patients must be able to give informed consent
Exclusion
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2038
Estimated Enrollment :
1780 Patients enrolled
Trial Details
Trial ID
NCT01840293
Start Date
February 1 2013
End Date
January 1 2038
Last Update
December 19 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Cork University Hospital
Cork, Ireland
2
Beaumont Hospital
Dublin, Ireland
3
St James's Hospital
Dublin, Ireland
4
St. Vincent's University Hospital
Dublin, Ireland